IN THE COURT OF APPEAL OF NEW ZEALAND
CA762/2008
[2008] NZCA 566BETWEENWATSON AND SON LIMITED
Appellant
ANDACTIVE MANUKA HONEY ASSOCIATION
Respondent
Hearing:15 December 2008
Court:Glazebrook, Robertson and Arnold JJ
Counsel:R B Stewart QC and K A Van Houtte for Appellant
G W Hall and B N White for Respondent
Judgment:19 December 2008 at 10.30 am
JUDGMENT OF THE COURT
A The appeal is dismissed.
BThe appellant must pay the respondent costs for a standard appeal on a Band A basis plus usual disbursements.
REASONS OF THE COURT
(Given by Arnold J)
Introduction
[1] This is an appeal from a decision of Panckhurst J refusing to grant the appellant interim orders: HC HAM CIV 2008-419-001495 5 December 2008.
[2] At the request of the parties, we heard the appeal as a matter of urgency. As we indicated at the hearing, we consider that this is a case which should be settled by the parties given the commercial interests that each has at stake and the nature of the legal issues. But if that is not possible, the case should go to a substantive hearing as soon as possible. The issues in the case are not well suited to adjudication at this interlocutory stage, even on a preliminary basis.
Background
[3] Briefly, the appellant, Watson & Son Ltd (Watson), produces manuka honey, most of which it exports, principally to the United Kingdom. Certain strains of manuka honey are known to have medicinal qualities greater than those normally associated with honey, in particular antibacterial qualities. The respondent, the Active Manuka Honey Association Inc (AMHA), owns the Unique Manuka Factor® and UMF® trade marks. Watson has entered into a licence agreement with AMHA to use the UMF® mark.
[4] AMHA, with the assistance of Professor Molan, developed a test to identify the antibacterial strength of manuka honey. Licenced users may use the UMF® mark on their products, together with a number (or “factor”) indicating the antibacterial strength of the particular product (eg, UMF®10). The factors go from 10 in increments to 30+, which indicates the honey with the strongest antibacterial properties. Consumers are prepared to pay a premium for honey having such properties.
[5] Honey is produced in batches. Under the licence arrangement, samples are taken from individual batches for testing by a designated testing agency. Depending on the result of the testing, the batch will be given a factor to indicate the antibacterial strength of the batch, and that will be included on the label of the individual jars of honey drawn from the batch. There may be as many as 5000 jars from one batch.
[6] Watson is a relatively new enterprise, which has expanded its operations rapidly. It has had considerable success in United Kingdom markets. It joined AMHA in 2006. At that time, although AMHA tested for the antibacterial strength factor using Professor Molan’s test, it had sought a report from him about the test’s reliability. Professor Molan recommended some changes to the test to improve its reliability in…
Keep reading for free
Create a free CaseChat account to read Watson and Son Limited v Active Manuka Honey Association and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2008] NZCA 566
- Decision Date
CaseChat Overview and Summary
The Court of Appeal considered the appeal on the basis of the pleadings as they currently stand, despite the appellant's suggestion that a cause of action under the Fair Trading Act 1986 might be added. The Court agreed with the High Court judge's approach to the application for interim orders, which involved assessing whether there was a serious question to be tried, the balance of convenience, and overall justice. The Court of Appeal's role was not to substitute its view for that of the Judge, but to consider whether the Judge acted on a wrong principle, failed to take account of some relevant matter, took some irrelevant matter into account or was "plainly wrong". The Court found that the Judge's assessment on the serious question issue was one that he could not properly have made. The Court also noted that the reliability or unreliability of the test was irrelevant, as the parties had agreed to be bound by the specified testing regime. The Court held that the issues could not sensibly be addressed, even on a preliminary basis, at this interlocutory stage. The Court agreed with the Judge that the significant evidence that some Watson product in the United Kingdom was not true to label was a powerful factor against granting the orders sought. The Court also held that there was no evidence before the Court to show that the appellant was able to meet its undertaking as to damages. The Court further noted that if the issues in the case were not well suited to adjudication at this interlocutory stage, they were even less so on a preliminary basis. The Court concluded that the appeal should be dismissed and the appellant must pay the respondent's costs for a standard appeal on a Band A basis plus usual disbursements.
Background
Background to the litigation
Watson filed proceedings in the High Court on 22 October 2008, alleging an anticipated breach of contract and improper interference with contractual relations. In conjunction with the statement of claim, Watson applied for interim orders to restrain AMHA from terminating the licence agreement, contacting Watson's distributors and purchasers, and implementing a product recall. Panckhurst J refused the application for interim orders. Watson appealed the decision to the Court of Appeal of New Zealand, which heard the appeal as a matter of urgency.
Decision
Reasons for decision
1. Whether the Court of Appeal should have allowed Watson's appeal against the High Court's refusal to grant interim orders.
2. Whether the Judge correctly identified the issues in the case and assessed the balance of convenience in the interim orders application.
Held
1. The Court of Appeal dismissed Watson's appeal against the High Court's refusal to grant interim orders.
2. The Court of Appeal found that the Judge correctly identified the issues in the case and assessed the balance of convenience in the interim orders application.
Ratio Decidendi
Legal Principle Established
The Court of Appeal considered that the appeal should be dismissed, and the decision of the High Court to refuse interim orders should stand. The Court observed that the appeal was from a decision of Panckhurst J refusing to grant interim orders, and the issues in the case were not well suited to adjudication at this interlocutory stage. The Court reviewed the approach taken by Panckhurst J, who had applied the correct legal principles in assessing the application for interim orders, considering the serious question to be tried, the balance of convenience, and overall justice. The Court of Appeal noted that the Judge had correctly identified the issues in the case and had not acted on a wrong principle, failed to take account of some relevant matter, or taken some irrelevant matter into account. The Court of Appeal found that the Judge's assessment on the serious question issue was one that he could not properly have made, and that the balance of convenience assessment was correctly made, taking into account the evidence of some Watson product in the United Kingdom not being true to label and the lack of evidence to show that Watson was able to meet its undertaking as to damages. The Court of Appeal agreed with the Judge that if this was an historical problem, it could be met without major disruption to Watson's operations. The ratio decidendi of this decision is that the Court of Appeal will not interfere with the Judge's exercise of discretion in assessing the application for interim orders unless there is a clear error in the approach taken or the evidence considered.